Eir Partners has acquired Accumulus Technologies, according to a news release.

Accumulus, founded in 2025 as a spinout of Accumulus Synergy and based in San Francisco, is a software-as-a-service company whose cloud platform enables life sciences organizations and global regulatory authorities to exchange data and collaborate on submissions.

Eir, founded in 2015 and based in Miami, is a middle market private equity firm focused on healthcare technology and tech-enabled services. Eir’s targeted stages of investment include growth equity through control buyouts and investment sizes ranging from $40 million to $150 million.

Terms of the transaction were not disclosed.

H.I.G. Capital recently announced that one of its affiliates had completed the acquisition of Outcomes One.

Outcomes, founded in 1977 and based in Orlando, Florida, is a provider of clinical network services and pharmacy technology.

H.I.G., founded in 1993 and based in Miami, pursues a wide range of investments in healthcare and many other industries. The firm has flexibility on investment size, including interest in pre-EBITDA businesses. Within healthcare, the firm targets companies in the provider services, hospital/major facilities and life sciences/pharmaceutical industries.

Terms of the transaction were not disclosed.

Thurston Group has acquired Pixel Health, according to a news release and a company announcement.

Pixel Health, founded in 2001 and based in Holyoke, Massachusetts, provides IT consulting and managed IT services to hospitals and large physician groups.

Thurston, founded in 1986 and based in Chicago, is a private equity firm focused on healthcare investments. The firm generally pursues companies with $1 million to $10 million in EBITDA.

Terms of the transaction were not disclosed.

BPOC recently announced strategic investments in Master Medical Equipment (MME) and ReNew Biomedical.

MME, founded in 2011 and based in Jackson, Tennessee, is a provider of EMS capital equipment, rentals and service.

ReNew, founded in 2014 and based in Jackson, Tennessee, services, repairs and maintains defibrillators, ventilators, infusion pumps, AEDs, ECGs and vital signs monitors.

MME and ReNew are sister companies.

BPOC, founded in 1996 and based in Chicago, seeks control and minority equity investments in lower middle market companies exclusively within the healthcare industry. The firm pursues companies generating at least $10 million in revenue through a wide range of investments. Within healthcare, the firm targets companies in the provider services, life sciences/pharmaceutical and non-reimbursement industries.

Terms of the investments were not disclosed.

Flexpoint Ford recently announced it sold ArtesRx to Linden Capital Partners.

ArtesRx, established in 2023 by Flexpoint and Dom Meffe, is a behavioral health pharmacy platform serving individuals who depend on complex medication regimens.

Flexpoint, founded in 2005 and based in Chicago, invests in the healthcare business and financial solutions and other sectors. The firm pursues investments from $50 million to $500 million in a single transaction, including investments in minority and majority structures in both private and public companies.

Linden, founded in 2004 and based in Chicago, is a private equity firm focused exclusively on the healthcare industry. The firm pursues acquisition opportunities across the healthcare industry, including services, products and distribution companies, and prefers to make more substantial investments from a dollars perspective.

Terms of the transaction were not disclosed.

SaaS is dead in the age of AI, say many in healthcare software.

Not so fast, says Noah Lewis, managing partner at Ardan Equity, a sector specialist at the intersection of healthcare, life sciences and technology. Arguing that the “SaaSpocalypse” is overblown, he joins McGuireWoods partner and host Geoff Cockrell to discuss AI’s impact on health tech. Noah explains how he screens for “melting ice cube risk” and sees commercialization, not technology cost, as the real competitive moat.

He also unpacks why healthcare’s aging $400 billion tech stack makes the present a golden age for health tech, and contends the market is shifting from inflationary to deflationary business models. It leads to one question: Who wins and loses as AI transforms healthcare?

Providence Equity Partners has announced it has entered into a definitive agreement to acquire a majority stake in CheckedUp.

CheckedUp, founded in 2012, is an education and engagement platform connecting patients, healthcare providers and life sciences companies at the point of care.

Providence, established in 1989 in Providence, Rhode Island, is a middle-market private equity firm focused on media, communications and education.

Varsity Healthcare Partners will join Providence as a minority investor in CheckedUp.

Terms of the transaction were not disclosed.

Francisco Partners (FP) has entered into a definitive agreement to acquire Weave Communications at an aggregate equity valuation of approximately $650 million, according to a news release.

Weave (NYSE: WEAV), founded in 2008 and based in Lehi, Utah, provides an AI-powered patient engagement and payments software platform for healthcare practices.

FP, founded in 1999 and based in San Francisco, is a private equity firm that specializes in investments in technology and technology-enabled businesses.

Upon completion of the transaction, expected in the fourth quarter of 2026, Weave will become a private company.

New Heritage Capital has invested in Carepoint Pharmacy, according to a news release.

Carepoint, founded in 2012 and based in Schaumburg, Illinois, is a platform that combines pharmacy dispensing capabilities with patient access hub services.

Heritage, founded in 2006 and based in Boston, is a private equity firm that pursues private IPO, management buyout and growth capital transactions. The firm invests in healthcare companies and a few other sectors, targeting platforms with $4 million to $30 million in EBITDA and investing $20 million to $100 million or more.

Terms of the investment were not disclosed.

Demand for concierge and functional medicine is surging, fueled by the GLP-1 boom and by healthcare costs increasingly shifting onto consumers. Fifth Third Securities managing director Chris Dorn describes this space, also known as “precision health,” as a consultative healthcare model where patients get more time with their physician and access to treatments standard primary care won’t provide.

In this conversation with McGuireWoods partner and host Geoff Cockrell, Chris digs into the details investors weigh: how much GLP-1 exposure sinks a deal’s appeal, and who actually buys these businesses once they reach real scale. Tune in for where the opportunity — and the traps — lie in one of healthcare’s fastest-emerging markets.